My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED

Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cybin Inc. Common Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Psychedelic Stock Gainers And Losers From March 9, 2022 ↗

March 09, 2022

GAINERS: ATAI Life Sciences (NASDAQ:

Via Benzinga

Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council ↗

March 09, 2022

DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ...

Via Benzinga

Psychedelic Stock Gainers And Losers From March 8, 2022 ↗

March 08, 2022

GAINERS: TripAdvisor (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From March 7, 2022 ↗

March 07, 2022

GAINERS: GH Research (NASDAQ:

Via Benzinga

Cybin Reports Adelia Milestone ↗

February 22, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Psychedelic Stock Gainers And Losers From March 4, 2022 ↗

March 04, 2022

GAINERS: Wellbeing Digital (OTC:

Via Benzinga

Psychedelic Stock Gainers And Losers From March 3, 2022 ↗

March 03, 2022

GAINERS: Seelos Therapeutics (NASDAQ:

Via Benzinga

Cybin Teams With Chopra Foundation To Foster Psychedelics Awareness ↗

March 03, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....

Via Benzinga

Psychedelic Stock Gainers And Losers From March 2, 2022 ↗

March 02, 2022

GAINERS: Mindset Pharma (OTC:

Via Benzinga

Psychedelic Therapies Offer Hope For Mental Health ↗

March 02, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....

Via Benzinga

Psychedelic Stock Gainers And Losers From March 1, 2022 ↗

March 01, 2022

GAINERS: Cybin (AMEX:

Via Benzinga

Psychedelic Stock Gainers And Losers From February 28, 2022 ↗

February 28, 2022

GAINERS: Wellbeing Digital (OTC:

Via Benzinga

Cybin's Study To Potentially Open New Frontiers In Psychedelics ↗

February 28, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....

Via Benzinga

Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

February 25, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

EXCLUSIVE: How This Company Backed By Deepak Chopra & Tony Robbins Is Disrupting Mental Health With Psychedelics ↗

February 25, 2022

Doug Drysdale, CEO of Cybin Inc. (NYSE:CYBN...

Via Benzinga

Psychedelic Stock Gainers And Losers From February 24, 2022 ↗

February 24, 2022

GAINERS: Seelos Therapeutics (NASDAQ:

Via Benzinga

Small Pharma, GH Research Among Top Psychedelic Movers Of Today ↗

February 23, 2022

GAINERS: Small Pharma (OTC:

Via Benzinga

Psychedelic Stock Gainers And Losers From February 22, 2022 ↗

February 22, 2022

GAINERS: LOSERS: Mindset Pharma (OTC:

Via Benzinga

Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study ↗

February 22, 2022

Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. ...

Via Benzinga

Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week ↗

February 21, 2022

An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt

Via Talk Markets

Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today ↗

February 18, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From February 17, 2022 ↗

February 17, 2022

GAINERS: Mindset Pharma (OTC:

Via Benzinga

Cybin Chopra Foundation Team To Advance Psychedelics In Mental Health ↗

February 16, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....

Via Benzinga

Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education ↗

February 15, 2022

Psychedelics-focused biotech company Cybin Inc. (NYSE:CYBN) ...

Via Benzinga

Psychedelic Stock Gainers And Losers From February 15, 2022 ↗

February 15, 2022

GAINERS: Mind Medicine (NASDAQ:

Via Benzinga

Cybin Turning Psychedelics-to-Therapeutics(TM) Vision Into Reality ↗

February 15, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....

Via Benzinga

Psychedelic Stock Gainers And Losers From February 14, 2022 ↗

February 14, 2022

GAINERS: Wellbeing Digital (OTC:

Via Benzinga

Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event ↗

February 14, 2022

Media company Global Trac Solutions, Inc. (OTCP:PSYC) and authorities behind psychedelic news and information platform Psy...

Via Benzinga

Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind' ↗

February 14, 2022

The psychedelics sector received its latest sign of acceptance from Wall Street with famed investor Cathie Wood taking a position ...

Via Benzinga

Mind Medicine, Cybin Among Top Psychedelic Movers Of Today ↗

February 11, 2022

GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.